Skip to main content

MoneyWorks4Me

Aurobindo Pharma informs about press release

29 Nov 2023 Evaluate
Aurobindo Pharma has informed that it enclosed a copy of the Press Release that is being issued by the Company in connection with USFDA approval received by the Company, for Darunavir Tablets, 600 mg and 800 mg.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1762.95
Dr. Reddys Labs. 1338.50
Cipla 1357.00
Lupin 1998.00
Zydus Lifesciences 1186.00
View more..